Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.71)
# 743
Out of 5,180 analysts
488
Total ratings
40.68%
Success rate
9.55%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGEN Precigen | Maintains: Buy | $9 → $10 | $3.87 | +158.40% | 15 | Mar 26, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $40.31 | +48.85% | 30 | Mar 25, 2026 | |
| OCGN Ocugen | Maintains: Buy | $7 → $10 | $1.81 | +452.49% | 23 | Mar 25, 2026 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $7 | $1.46 | +379.45% | 12 | Mar 24, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterates: Buy | $130 | $92.38 | +40.72% | 6 | Mar 23, 2026 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $37 → $52 | $24.68 | +110.70% | 10 | Mar 20, 2026 | |
| LFWD Lifeward | Maintains: Buy | $4.5 → $10 | $6.61 | +51.29% | 9 | Mar 19, 2026 | |
| INAB IN8bio | Reiterates: Buy | $6 | $1.48 | +305.41% | 16 | Mar 13, 2026 | |
| ALXO ALX Oncology Holdings | Reiterates: Buy | $4 | $2.01 | +99.50% | 16 | Mar 10, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $47 → $130 | $83.92 | +54.91% | 9 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.63 | +340.76% | 15 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $64 | $32.17 | +98.94% | 19 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $6.03 | +198.51% | 14 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.28 | +223.28% | 16 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.13 | +87.79% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.65 | - | 17 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.00 | +166.67% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $13.90 | +223.74% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $16.11 | +123.46% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.74 | +629.93% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $102.48 | +51.25% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $114.14 | -17.65% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $17.84 | +79.37% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $6.37 | +104.08% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $4.13 | +21.07% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7,500 | $3.10 | +241,835.48% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.28 | +290.63% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.58 | +234.35% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.83 | +261.45% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.54 | +1,952.24% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.21 | +578.73% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.61 | +394.48% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.77 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.01 | +197.03% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.47 | +138.10% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $3.72 | +410.75% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $4.64 | +611.21% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $5.88 | +2,025.85% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.95 | +178.48% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.54 | +3,603.70% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $7.20 | +25.00% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.86 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.33 | +1,779.70% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.92 | +27.55% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.54 | +4,624.41% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.16 | +12,322.36% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.59 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $14.63 | -58.99% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.13 | +1,227.43% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.30 | +522.64% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $10.88 | -12.68% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $0.74 | +1,879,346.91% | 1 | Mar 5, 2020 |
Precigen
Mar 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $3.87
Upside: +158.40%
Corcept Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $40.31
Upside: +48.85%
Ocugen
Mar 25, 2026
Maintains: Buy
Price Target: $7 → $10
Current: $1.81
Upside: +452.49%
Pyxis Oncology
Mar 24, 2026
Reiterates: Buy
Price Target: $7
Current: $1.46
Upside: +379.45%
Mirum Pharmaceuticals
Mar 23, 2026
Reiterates: Buy
Price Target: $130
Current: $92.38
Upside: +40.72%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $37 → $52
Current: $24.68
Upside: +110.70%
Lifeward
Mar 19, 2026
Maintains: Buy
Price Target: $4.5 → $10
Current: $6.61
Upside: +51.29%
IN8bio
Mar 13, 2026
Reiterates: Buy
Price Target: $6
Current: $1.48
Upside: +305.41%
ALX Oncology Holdings
Mar 10, 2026
Reiterates: Buy
Price Target: $4
Current: $2.01
Upside: +99.50%
Dianthus Therapeutics
Mar 9, 2026
Maintains: Buy
Price Target: $47 → $130
Current: $83.92
Upside: +54.91%
Mar 9, 2026
Reiterates: Buy
Price Target: $16
Current: $3.63
Upside: +340.76%
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $32.17
Upside: +98.94%
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $6.03
Upside: +198.51%
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $9.28
Upside: +223.28%
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.13
Upside: +87.79%
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.65
Upside: -
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $3.00
Upside: +166.67%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $13.90
Upside: +223.74%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $16.11
Upside: +123.46%
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $2.74
Upside: +629.93%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $102.48
Upside: +51.25%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $114.14
Upside: -17.65%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $17.84
Upside: +79.37%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $6.37
Upside: +104.08%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $4.13
Upside: +21.07%
Nov 4, 2025
Assumes: Buy
Price Target: $7,500
Current: $3.10
Upside: +241,835.48%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.28
Upside: +290.63%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.58
Upside: +234.35%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.83
Upside: +261.45%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.54
Upside: +1,952.24%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.21
Upside: +578.73%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.61
Upside: +394.48%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.77
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.01
Upside: +197.03%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.47
Upside: +138.10%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $3.72
Upside: +410.75%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $4.64
Upside: +611.21%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $5.88
Upside: +2,025.85%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $3.95
Upside: +178.48%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.54
Upside: +3,603.70%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $7.20
Upside: +25.00%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.86
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.33
Upside: +1,779.70%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $3.92
Upside: +27.55%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.54
Upside: +4,624.41%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.16
Upside: +12,322.36%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.59
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $14.63
Upside: -58.99%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.13
Upside: +1,227.43%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.30
Upside: +522.64%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $10.88
Upside: -12.68%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $0.74
Upside: +1,879,346.91%